Market Summary

The global dermal fillers market was valued at USD 4.98 billion in 2021 and it is the need for minimally invasive aesthetic procedures, particularly in developed nations, is a major factor in the market's growth. The global dermal fillers market is expected to grow at a CAGR of 7.44% during the forecast period to reach USD 9.45 billion by 2030. High patient satisfaction from product development will also have a beneficial effect on product demand during the predicted period. In the coming years, it is anticipated that ongoing advancements in filler materials will have an impact on the market expansion. Numerous products intended for particular facial regions have received FDA approval, enabling dermatologists to provide clients with specialized care. The filler can be used to treat moderate to severe facial creases and wrinkles. Recent innovations, such as HA filler for subtle lip enhancement that improves lip definition without increasing lip size, will also raise public preference for dermal filler procedures.

Dermal fillers are injected under the skin and are soft, gel-like materials. Deep under-eye bags, lifting of the cheekbones, volumization of the lips, smoothing of lip lines and nasolabial folds (the wrinkles that run from the side of the nose to the corners of the mouth), and hand rejuvenation are a few of the frequent issues they can treat.

“Rising Interest in Cosmetic Operations Globally Fuels the Market”

The development of the dermal filler market will be supported throughout the projected period by an expanding network of healthcare facilities offering cutting-edge aesthetic treatments and improved infrastructure. The number of clinics, medical spas, and centers for rejuvenation has significantly increased in recent years both in industrialized and developing countries. Thus, the rapid adoption of various non-invasive treatments offered by these facilities owing to the benefits including the cost-effectivity and shorter treatment duration will propel the industry growth. Furthermore, escalating number of skilled professionals such as dermatologists and plastic surgeons will further augment the industry expansion.


To learn more about this report, request a free sample copy


The global dermal filler market is segmented based on application, product, and end -users.

By Application Outlook:

Based on application, the dermal filler market is segmented into scar treatment, wrinkle correction treatment, lip enhancement, restoration of volume/fullness, and others. Due to a higher demand for these kinds of procedures, the wrinkle correction segment accounted for the largest share of the application segment. In addition, it is projected that this category would expand as a result of new product launches targeted at it. Teoxane's RHA Redensity, which can be used to lessen the appearance of facial lines and wrinkles, received FDA approval in January 2022.

Due to the high amount of lip treatments, the lip augmentation segment made up the second-largest segment. The category is anticipated to be driven by the increased demand for cosmetic enhancements of the lips, which is being fueled by the advent of minimally invasive procedures. Due to product introductions like Allergan's (AbbVie, Inc.) JUVEDERM VOLUX, the volume/fullness category is expected to make a comeback and rank third among all segments. In the foreseeable term, it is anticipated that scar therapy would represent a relatively smaller market share.

By Product Outlook:

Based on the product, the dermal filler market is segmented into biodegradable and non-biodegradable. The segment that uses biodegradable materials is predicted to have the largest market share over the forecast period. The greater availability of product options in this sector compared to non-biodegradable products and the wider range of aesthetic uses of biodegradable products are responsible for the segment's higher market share.

The increased level of safety and solid regulatory approval for the products, as well as the current R&D initiatives of large and emerging businesses to offer new products in the biodegradable category, are all anticipated to support the segment's expansion. Because these items are permanent in nature and hence have much lower adoption rates, the non-biodegradable group had a smaller market share in 2021. Non-biodegradable materials are not combustible and do not degrade like temporary and semi-permanent fillers do.

 By End-Users Outlook:

Based on the end-users, the dermal fillers market is segmented into specialty & dermatology clinics, hospitals & clinics, and others. During the forecast period, it is anticipated that the specialty & dermatology clinics category will dominate. A significant number of aesthetic operations performed in dermatology and specialty clinics are responsible for the segment's dominance. The main driving force for the segment's expansion is this. Furthermore, because cosmetic operations like wrinkle removal don't require a hospital stay, these elements are predicted to assist the segment's growth. A large number of aesthetic procedures, such as face injectables, are performed in hospitals and clinics, which contributed to the segment's second-highest market share in 2021. A relatively lower market growth rate and market revenue share are anticipated for the others category throughout the projection period.


On the basis of geography, the dermal fillers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.


To learn more about this report, request a free sample copy

Throughout the projected period, North America will continue to be one of the most attractive markets for dermal fillers. The region's high disposable income, good ability to spend on cosmetic operations, the presence of top manufacturers and the expanding demand for non-surgical procedures in the region are some of the main drivers promoting expansion.

During the projected period, Europe is anticipated to hold the second-largest market share for dermal fillers. The region's market is expected to be significantly influenced by the rising demand for minimally invasive methods of face enhancement in the ensuing years. Another important factor that is anticipated to increase the regional market share for dermal fillers is the rising number of product approvals and product availability.

Due to the rising geriatric population and rising per capita income, APAC is anticipated to expand at the fastest CAGR throughout the projection period. Another significant factor that is anticipated to propel the market in the area during the assessment period is the increased demand for non-invasive cosmetic procedures and products for facial aesthetics. Due to the presence of profitable chances that might accelerate the industry, the presence of growing nations like India, China, and Japan is anticipated to significantly enhance the regional market.

By Key Competitors and Market Share Analysis:

To increase their consumer base in the worldwide market, the majority of significant competitors are implementing a variety of competitive methods, including acquisition, mergers, and alliances. They are also emphasizing expanding their product lines. Numerous advances and product innovations are anticipated as a result of the rising demand for minimally invasive cosmetic procedures, giving them an advantage over their rivals.

Recent Developments:

  • In March 2021, with a modified administration regimen, Galderma announced the reintroduction of Sculptra (injectable Poly-L-lactic acid) in Europe.
  • In February 2021, the injectable hyaluronic acid filler BELOTERO BALANCE (+) with lidocaine has been launched in the United States, according to Merz Esthetics.

The following are some of the major market players operating across the globe:

o    Galderma Pharma S.A.

o    Sinclair Pharma PLC

o    Zimmer Biomet Holdings

o    Allergan PLC.

o    Merz Aesthetics

o    Anika Therapeutics

o    Suneva Medical Inc.

o    Laboratories Vivacy SAS

Report Covering


Market size value in 2021

USD 46.43 billion

Revenue forecast in 2030

USD 74.90 billion

Growth rate

CAGR of 5.53 % from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2022 to 2030

Report coverage

Market dynamics such as Drivers, Restraints, Market Trends and Opportunities, Revenue size, market share, company ranking, competitive landscape, geographical presence, recent developments, strategic initiatives, and overall contribution to the market.

Segments covered

Application, Product, End-Users, Region

Regional scope

North America; Europe; Asia Pacific; Latin America; and Middle East & Africa.

Country Scope

U.S.; Canada; Germany; France; U.K.; Italy; Spain; China; Japan; India; South Korea; Mexico; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa

Key companies profiled

Galderma Pharma S.A., Sinclair Pharma PLC, Zimmer Biomet Holdings, Allergan PLC., Merz Aesthetics, Anika Therapeutics Suneva Medical Inc., Laboratories Vivacy SAS.

Customization scope

We also provide customized reports and If the information you seek is not included in the current scope of the study, kindly share your specific requirements (any category, subcategory, company profile, region, etc.), and we can have a feasibility check and we could incorporate the same as a part of report customization at no additional cost.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options click to buy or write us at  

 To know more about the study, please click here


This report projected revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Quintile Insights has segmented the global dermal fillers market report based on application, product, end-users, and region:

Application Insights: Revenue in USD Million (2017 - 2030)

o    Scar Treatment

o    Wrinkle Correction Treatment

o    Lip Enhancement

o    Restoration of Volume/ Fullness

o    Others

Product Channel Insights: Revenue in USD Million (2017 - 2030)

o    Biodegradable

o    Non-Biodegradable

End-Users Insights: Revenue in USD Million (2017 - 2030)

o    Speciality & Dermatology Clinics

o    Hospitals & Clinics

o    Others

Regional Insights: Revenue in USD Million (2017 - 2030)

o    North America



o    Europe






o    Asia Pacific





South Korea


o    Latin America 





o    Middle East & Africa

Saudi Arabia


South Africa

Frequently Asked Questions

The global dermal fillers market is predicted to develop at a compound annual growth rate of 5.53 % from 2022-2030 to reach up to USD 74.90 billion by 2030.

The global dermal fillers market was valued at USD 46.43 billion in 2021.

North America dominated the market, accounting for about 39.92 % of the global market in 2021.

Some of the key market players operating in the pressure relief mattress market are Galderma Pharma S.A., Sinclair Pharma PLC, Zimmer Biomet Holdings, Allergan PLC., Merz Aesthetics, Anika Therapeutics Suneva Medical Inc., Laboratories Vivacy SAS.

The reasons driving the market expansion include rising interest in cosmetic operations, an increase in facial soft tissue trauma, and robust research and development in dermal fillers.